Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva News - Latest teva News, Information & Updates - Health News -ET HealthWorld
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva shares surge after announcing global opioid settlement
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva to settle opioid-related claims in Florida for $117 million | The Times of Israel
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement
teva News and latest stories | The Jerusalem Post
Today's News: FBI Raids NY Yeshiva; Layoffs at Israel's Teva Pharmaceuticals; and more - Tablet Magazine
San Francisco reaches $58m opioid settlement with Teva, Allergan | Drugs News | Al Jazeera
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Is Teva Pharmaceutical Industries (NYSE:TEVA) A Risky Investment? - Simply Wall St News
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals USA - News, Articles etc. - European Pharmaceutical Review
New York could get $524M under opioid settlements with Teva - ABC News
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva CEO Schultz likely won't renew employment contract: reports
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva Pharmaceuticals responsible for fueling opioid crisis, New York jury finds - JURIST - News
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
